Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Additional Information (Detail)

v2.4.0.6
Stockholders' Equity - Additional Information (Detail) (USD $)
1 Months Ended 2 Months Ended 3 Months Ended 1 Months Ended 2 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended
Oct. 29, 2012
Aug. 31, 2012
Sep. 30, 2012
Sep. 30, 2011
Jun. 30, 2012
Jun. 14, 2012
Jun. 30, 2011
Aug. 31, 2011
Common Stock [Member]
Aug. 31, 2012
Common Stock [Member]
Sep. 30, 2012
Common Stock [Member]
Aug. 31, 2011
Warrant [Member]
Sep. 30, 2012
Warrant [Member]
Jun. 30, 2010
Restatement Adjustment [Member]
Sep. 30, 2011
Selling, General and Administrative Expenses [Member]
Sep. 30, 2011
Research and Development Expense [Member]
Jun. 14, 2012
Stock Option Plan 2010 [Member]
Jun. 30, 2012
June 2012 Warrants [Member]
Sep. 30, 2012
June 2012 Warrants [Member]
Jun. 30, 2011
June 2012 Warrants [Member]
Jun. 14, 2012
Advisory Agreement [Member]
Jun. 14, 2012
Advisory Agreement [Member]
Restricted Stock
Jun. 30, 2012
Private Placement [Member]
Sep. 30, 2012
Private Placement [Member]
Sep. 30, 2012
Deferred Compensation, Share-Based Payments [Member]
Oct. 30, 2012
Subsequent Event [Member]
Private Placement [Member]
Jun. 14, 2012
Flux Power Inc [Member]
Stockholders Equity Note Disclosure [Line Items]                                                    
Common stock, authorized     145,000,000   145,000,000                                          
Common stock, par value     $ 0.001   $ 0.001                                          
Preferred stock, authorized     5,000,000   5,000,000                                          
Preferred stock, par value     $ 0.001   $ 0.001                                          
Preferred stock, issued     0   0                                          
Preferred stock, outstanding     0   0                                          
Shares issued as part of Flux Power Inc. acquisition                                                   37,714,514
Shares of common stocks issued 100,000   2,293,567         603,594     120,719           2,813,000       100,000 1,207,185     241,437  
Warrants issued     458,732                           562,551           2,859,060   48,287  
Net proceeds from issuance of common stock and warrants $ 4,000   $ 901,000 $ 0                         $ 1,126,000                  
Advisory service agreement period                                       24 months            
Warrant to purchase restricted shares of common stock                                       1,837,777 1,837,777          
Warrant term                                       5 years   5 years     5 years  
Common stock initial exercise price   $ 0.41                                   $ 0.41   $ 0.41        
Shares of common stock outstanding under the option plan     4,536,949   4,536,949   2,097,841           2,097,841     1,535,500     710,000              
Allocated share-based compensation expense       1,000                   300 700                      
Accredated Investor Unit   250,000             2,000,000                         500,000        
Common Stock Unit   603,594                                                
Warrant Units   120,719                                                
Prepaid Advisory Fees           3,258,000                                        
Amortization of prepaid advisory fees     407,000 0                                            
Warrants exercise price   $ 0.41                                   $ 0.41   $ 0.41        
Proceeds from Issuance or Sale of Equity     672,000             1,690,063 231,000 338,013                            
Stock Issued During Period Shares Stock Options Exercised     0                             2,000,000                
Stock or Unit Option Plan Expense     406,000                                              
Stock Options Expense Expected To Be Recognized     5 years 9 months 28 days                                              
Stock-based compensation     45,000 1,000                                            
Selling and administrative expenses     714,000 331,000                                       41,000    
Research and development     290,000 79,000                                       4,000    
Derivative Asset, Fair Value, Net     $ 2,783,000